Anavex Life Sciences Corp. (AVXL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.24 |
| Open | 5.21 |
| Bid | 5.12 x 200 |
| Ask | 5.15 x 200 |
| Day's range | 5.10 - 5.30 |
| 52-week range | 3.25 - 10.45 |
| Volume | |
| Avg. volume | 909,381 |
| Market cap | 435.001M |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
Anavex Life Sciences Corp (AVXL) reports a robust cash runway and significant progress in Alzheimer's treatment, despite facing regulatory and trial challenges.
- Simply Wall St.
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
We feel now is a pretty good time to analyse Anavex Life Sciences Corp.'s ( NASDAQ:AVXL ) business as it appears the...
- Associated Press Finance
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot
NEW YORK (AP) — Anavex Life Sciences Corp. AVXL) on Tuesday reported a loss of $12.2 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had a loss of 14 cents.
© 2024 Yahoo. All rights reserved.